Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer
Stopped Study terminated by PI due to inability to accrue.
Conditions
- Stage IVA Colorectal Cancer
- Stage IVB Colorectal Cancer
Interventions
- BIOLOGICAL: Cetuximab
- DRUG: Fluorouracil
- DRUG: Irinotecan Hydrochloride
- DRUG: Leucovorin Calcium
Sponsor
University of Chicago
Collaborators